tiprankstipranks
Trending News
More News >
AN2 Therapeutics, Inc. (ANTX)
NASDAQ:ANTX
US Market

AN2 Therapeutics, Inc. (ANTX) Income Statement

Compare
105 Followers

AN2 Therapeutics, Inc. Income Statement

Last quarter (Q4 2025), AN2 Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, AN2 Therapeutics, Inc.'s net income was $-8.71M. See AN2 Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ -77.00K$ 0.00
Operating Expenses
$ 38.11M$ 54.55M$ 69.64M$ 42.19M$ 21.57M
Depreciation and Amortization
$ 0.00$ 54.55M$ 69.64M$ 77.00K$ 0.00
EBITDA
$ -38.11M$ 3.23M$ 4.90M$ -40.88M$ -21.57M
Operating Income
$ -38.11M$ -54.55M$ -69.64M$ -42.26M$ -21.57M
Other Income/Expenses
$ 2.94M$ 3.23M$ 4.90M$ 1.31M$ 31.00K
Pretax Income
$ -35.17M$ -51.32M$ -64.73M$ -40.96M$ -21.54M
Net Income
$ -35.17M$ -51.32M$ -64.73M$ -40.96M$ -21.54M
Per Share Metrics
Basic EPS
$ -1.16$ -1.72$ -2.74$ -2.79$ -1.50
Diluted EPS
$ -1.16$ -1.72$ -2.74$ -2.79$ -1.50
Weighted Average Shares Outstanding
30.22M 29.83M 23.60M 15.34M 18.74M
Weighted Average Shares Outstanding (Diluted)
30.22M 29.83M 23.60M 15.34M 18.74M
Currency in USD

AN2 Therapeutics, Inc. Earnings and Revenue History